NPPB and hydrops fetalis: The BeAT-HF trial (HFrEF, NYHA II/III, LVEF ≤ 35%, optimal medical management) found BAT safe and significantly improved quality of life, 6MWT distance, and NT-proBNP at 6 months versus medical therapy alone [36].